These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35932128)

  • 1. Comparison of HIV-related Ocular Involvement in HAART-naive and HAART-treated Patients.
    Mahsood YJ; Bano M; Farooq S; Khalil MZUD
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1033-1036. PubMed ID: 35932128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional study.
    Singalavanija T; Ausayakhun S; Tangmonkongvoragul C
    PLoS One; 2018; 13(2):e0193161. PubMed ID: 29466424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations of HIV infection at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
    Ismail I; Venter M; Ismail S; Ally N
    S Afr Med J; 2023 Oct; 113(10):20-24. PubMed ID: 37881908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
    Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular manifestations in HIV/AIDS patients undergoing highly active antiretroviral treatment (HAART) in Togo].
    Ayena KD; Amedome KM; Agbo AR; Kpetessou-Ayivon AL; Dzidzinyo BK; Djagnikpo PA; Banla M; Balo KP
    Med Trop (Mars); 2010 Apr; 70(2):137-40. PubMed ID: 20486347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
    Shah SU; Kerkar SP; Pazare AR
    Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular findings in human immunodeficiency virus patients in Washington, DC.
    Kaleem MA; Ramsahai S; Del Fierro K; Rasul S; Onumah C; Lerebours V; Gajjala J; Copeland RA; Jones LS
    Int Ophthalmol; 2012 Apr; 32(2):145-51. PubMed ID: 22450559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy.
    Sudharshan S; Menia NK; Selvamuthu P; Tyagi M; Kumarasamy N; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1887-1893. PubMed ID: 32823409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
    Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
    BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
    Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function: A Prospective Case-Control Study From Cameroon.
    Fokouo JV; Vokwely JE; Noubiap JJ; Nouthe BE; Zafack J; Minka Ngom ES; Dalil AB; Ngo Nyeki AR; Bengono G; Njock R
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):436-41. PubMed ID: 25741887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon.
    Pangmekeh PJ; Awolu MM; Gustave S; Gladys T; Cumber SN
    Pan Afr Med J; 2019; 33():87. PubMed ID: 31489065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.
    Bergersen BM; Sandvik L; Dunlop O; Birkeland K; Bruun JN
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):731-6. PubMed ID: 14610658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.